4.2 Review

Intravenous Diltiazem Versus Metoprolol in Acute Rate Control of Atrial Fibrillation/Flutter and Rapid Ventricular Response: A Meta-Analysis of Randomized and Observational Studies

Related references

Note: Only part of the references are listed.
Article Emergency Medicine

Intravenous diltiazem versus metoprolol for atrial fibrillation with rapid ventricular rate: A meta-analysis

Qingsu Lan et al.

Summary: The meta-analysis results indicate that intravenous diltiazem has higher efficacy and shorter average onset time compared to intravenous metoprolol, with lower impact on ventricular rate and blood pressure. There is no significant difference in adverse events between the two drugs.

AMERICAN JOURNAL OF EMERGENCY MEDICINE (2022)

Article Pharmacology & Pharmacy

Intravenous Metoprolol Versus Diltiazem for Rate Control in Atrial Fibrillation

Sheng Qi Xiao et al.

Summary: This study compared the efficacy and safety of IV metoprolol and diltiazem for rate control in AF, finding no significant difference in rate control achievement, time to rate control, or adverse events between the two medications. Patient-specific factors do not seem to influence the preference for one medication over the other.

ANNALS OF PHARMACOTHERAPY (2022)

Article Emergency Medicine

Acute management of atrial fibrillation in congestive heart failure with reduced ejection fraction in the emergency department

Michael Hasbrouck et al.

Summary: This study compared the incidence of adverse effects in heart failure patients with atrial fibrillation and rapid ventricular response who were treated with intravenous diltiazem or metoprolol. While the overall adverse effects were similar, the diltiazem group had a significantly higher incidence of worsening heart failure symptoms.

AMERICAN JOURNAL OF EMERGENCY MEDICINE (2022)

Review Cardiac & Cardiovascular Systems

Comparison of diltiazem and metoprolol for atrial fibrillation with rapid ventricular rate: Systematic review and meta-analysis

Saurabh C. Sharda et al.

Summary: Intravenous diltiazem is more effective than metoprolol in achieving rate control target in patients with AF-RVR, while both medications have similar incidence rates of hypotension and bradycardia.

INDIAN HEART JOURNAL (2022)

Article Emergency Medicine

Intravenous metoprolol versus diltiazem for atrial fibrillation with concomitant heart failure

Chad T. Compagner et al.

Summary: This retrospective study evaluated the effectiveness and safety of IVP metoprolol or diltiazem in the treatment of heart failure patients with concomitant atrial fibrillation and rapid ventricular response. The study found that IVP diltiazem was more effective and quicker in reducing heart rate compared to IVP metoprolol, with similar safety outcomes.

AMERICAN JOURNAL OF EMERGENCY MEDICINE (2022)

Article Emergency Medicine

Evaluation of the blood pressure effects of diltiazem versus metoprolol in the acute treatment of atrial fibrillation with rapid ventricular rate

Stephany Nunez Cruz et al.

Summary: The study found that there was no significant difference in blood pressure effects between diltiazem and metoprolol intravenous push in the acute management of atrial fibrillation with rapid ventricular rate. Both medications demonstrated similar effectiveness in improving blood pressure levels in patients with this condition.

AMERICAN JOURNAL OF EMERGENCY MEDICINE (2021)

Article Critical Care Medicine

Comparative Effectiveness of Heart Rate Control Medications for the Treatment of Sepsis-Associated Atrial Fibrillation

Nicholas A. Bosch et al.

Summary: In a large cohort of patients with sepsis and AF with rapid ventricular response, a (3-blocker treatment strategy was associated with improved HR control at 1 h, but generally similar HR control at 6 h compared with amiodarone, calcium channel blocker, or digoxin.

CHEST (2021)

Editorial Material Emergency Medicine

Diltiazem versus metoprolol for the management of atrial fibrillation: A systematic review and meta-analysis

S. Hammad Jafri et al.

AMERICAN JOURNAL OF EMERGENCY MEDICINE (2021)

Article Emergency Medicine

Evaluation of metoprolol versus diltiazem for rate control of atrial fibrillation in the emergency department

Patrick McGrath et al.

Summary: This study compared the effectiveness and safety of metoprolol and diltiazem administration in the Emergency Department for rate control of supraventricular tachycardia. The results showed no significant difference in acute rate control effectiveness between metoprolol and diltiazem, but a significantly higher occurrence of hypotension in the diltiazem group, primarily driven by diastolic blood pressures less than 60 mmHg.

AMERICAN JOURNAL OF EMERGENCY MEDICINE (2021)

Review Cardiac & Cardiovascular Systems

The Evolution of β-Blockers in Coronary Artery Disease and Heart Failure (Part 1/5)

Philip Joseph et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)

Article Medicine, General & Internal

RoB 2: a revised tool for assessing risk of bias in randomised trials

Jonathan A. C. Sterne et al.

BMJ-BRITISH MEDICAL JOURNAL (2019)

Article Pharmacology & Pharmacy

Diltiazem versus metoprolol for rate control in atrial fibrillation with rapid ventricular response in the emergency department

Michelle C. Hines et al.

AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY (2016)

Article Cardiac & Cardiovascular Systems

Estimates of Current and Future Incidence and Prevalence of Atrial Fibrillation in the US Adult Population

Susan Colilla et al.

AMERICAN JOURNAL OF CARDIOLOGY (2013)

Article Medicine, General & Internal

Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement

David Moher et al.

ANNALS OF INTERNAL MEDICINE (2009)

Article Medicine, General & Internal

Meta-analysis of observational studies in epidemiology - A proposal for reporting

DF Stroup et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2000)